Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device aims to ease tennis elbow without drugs

NCT ID NCT07495254

Symptom relief Sponsor: University of Vic - Central University of Catalonia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a device called Super Inductive System (SIS), combined with exercise and health education, can reduce pain and improve function in people with tennis elbow. About 224 adults with confirmed tennis elbow will receive either real SIS or a placebo version, plus standard exercise and education. Researchers will measure pain, grip strength, and quality of life over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Super Inductive System (SIS) device
What this could lead to
If it works, this could provide a new, non-invasive treatment option for tennis elbow that reduces pain and speeds recovery.
What could go wrong
This trial hasn't started yet and is relatively small. The control group also gets exercise and education, so any added benefit from SIS may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 224 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Clinical diagnosis of lateral elbow tendinopathy confirmed by a Family Care Physician, Rehabilitation Physiatrist, Orthopedic Surgeon, or Rheumatologist. * Referral to one of the three participating Rehabilitation and Physical Therapy Services (Mataró, Sant Andreu, or Drassanes). * Presence of at least one positive provocative test (Cozen's test or Mill's test). * Ability and willingness to participate in the study after reading the patient information sheet and signing the informed consent, including consent for image use. Exclusion Criteria: * Medial elbow tendinopathy. * Recent traumatic injury to the affected upper limb within the past 6 months. * Passive elbow joint range of motion limited by more than 20°. * Injection in the affected elbow within 6 weeks prior to baseline assessment. * Systemic inflammatory, autoimmune, infectious, or neoplastic disease. * Pregnancy. * Metal implants in the affected elbow region. * Pacemaker or implantable defibrillator. * Radial tunnel syndrome / Frohse arcade syndrome. * Coagulation disorders. * Cognitive or sensory impairment that precludes participation in the study procedures. * Central sensitization syndromes (e.g., fibromyalgia, chronic fatigue syndrome).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lateral elbow tendinopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epicondylitis Motor Activity Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lateral elbow tendinopathy Lateral epicondylalgia Lateral epicondylitis (tennis elbow)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Anna Escribà Salvans

    Mataró, Barcelona, 08303, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.